Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy
Clinical trial NCT02769169 · TERMINATED
Trial details
- NCT number
- NCT02769169
- Sponsor
- Sun Yat-sen University
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2018-09-12
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.